01238nam a22001577a 4500999001900000008004100019100003600060245008400096260003500180300003300215520066800248773003500916906001400951942000700965952010800972  c525955d525955240426b           ||||| |||| 00| 0 eng d  aAtal, Juan Pablo et al  951910  a The economics of the public option: Evidence from local pharmaceutical markets  aThe American Economic Review    a114(3), Mar, 2024: p.615-644  aWe study the effects of competition by state-owned firms, leveraging the decentralized entry of public pharmacies to local markets in Chile. Public pharmacies sell the same drugs at a third of private pharmacy prices, because of stronger upstream bargaining and market power in the private sector, but are of lower quality. Public pharmacies induced market segmentation and price increases in the private sector, which benefited the switchers to the public option but harmed the stayers. The countrywide entry of public pharmacies would reduce yearly consumer drug expenditure by 1.6 percent.- Reproduced 

https://www.aeaweb.org/articles?id=10.1257/aer.20211547
  aThe American Economic Review    aECONOMICS  cAR  00102ddc40709401009aIIPAbIIPAd2024-04-26h114(3), Mar, 2024: p.615-644pAR131748r2024-04-26yAR